DARK SECRETS: 2 | Vintage Vibes

Altimmune: Q4 Earnings Insights

  Altimmune (NASDAQ:ALT) reported its Q4 earnings results on Tuesday, March 15, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Benzinga · Mar 15, 2022

Altimmune's Earnings Outlook

Altimmune (NASDAQ:ALT) is set to give its latest quarterly earnings report on Monday, 2022-03-14. Here's what investors need to know before the announcement. Analysts estimate that Altimmune will report an earnings per share (EPS) of $-0.65.

Benzinga · Mar 11, 2022

Altimmune's Mid-Stage Pemvidutide Study Cleared By FDA For Obesity

The FDA has cleared Altimmune Inc's (NASDAQ:

Benzinga · Jan 31, 2022